Evidence-Based Information For Psychedelics (EBI-Psychedelics)

A living synthesis of the scientific literature on psychedelics, inspired by the U-REACH framework.

How It Works?

The EBI-Psychedelics will enable you to gain cutting-edge best scientific knowledge about efficacy and safety of psychedelics interventions. Use this knowledge to engage in an informed healthcare professional x people with lived experience decision-making process!

Interventions

Gather general knowledge about all psychedelic interventions identified in the scientific literature.

01
Interventions illustration
Preference illustration
02

Preference

Use our multi-criteria decision-making tool to identify the interventions that best align with personal values and key outcomes to focus on.

Discussion

The knowledge contained in this platform should streamline informed discussions between healthcare professional and people with lived experience.

03
Discussion illustration

Team behind the U-REACH project

The U-REACH initiative aims to bridge the gap between high-quality evidence-based research and the general public. In line with U-REACH goals, this platform is designed to serve as an ideal interface for fostering informed, collaborative decision-making about the therapeutic use of psychedelics, facilitating meaningful dialogue between clinicians and individuals with lived experience.

Marco Solmi
MD, PhD
Canada University of Ottawa
Germany Charité University Medicine
Corentin J. Gosling
PhD
France Université Paris Nanterre
UK University of Southampton
Samuele Cortese
MD, PhD
Spain University of Southampton
Italy University of Bari "Aldo Moro"

Leaders of the EBI-Psychedelics project

Marco Solmi
MD, PhD
Canada University of Ottawa
Germany Charité University Medicine
Mikkel Højlund
MD, PhD
France University of Southern Denmark
Corentin J. Gosling
PhD
France Université Paris Nanterre
UK University of Southampton
Areti Angeliki Veroniki
PhD
Spain University of Toronto